David Matthews
Emeritus Professor of Diabetes Medicine
- Emeritus Founding Chairman, Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM)
- Dean of Degrees and Emeritus Fellow of Harris Manchester College, Oxford
Recent publications
Sodium-glucose co-transporter-2 inhibitors: A paradigm shift in treatment for type 2 diabetes.
Journal article
Matthews DR., (2024), Diabetes Obes Metab, 26 Suppl 5, 3 - 4
Effects of sodium-glucose co-transporter-2 inhibitors by background cardiovascular medications: A systematic review and meta-analysis.
Journal article
Avgerinos I. et al, (2023), Diabetes Obes Metab, 25, 3020 - 3029
Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis.
Journal article
Karagiannis T. et al, (2022), Diabetologia, 65, 1251 - 1261
Effects of canagliflozin on myocardial infarction: a post hoc analysis of the CANVAS programme and CREDENCE trial.
Journal article
Yu J. et al, (2022), Cardiovasc Res, 118, 1103 - 1114
Sotagliflozin for patients with type 2 diabetes: A systematic review and meta-analysis.
Journal article
Avgerinos I. et al, (2022), Diabetes Obes Metab, 24, 106 - 114
